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Abstract. 
 
Platelet integrin 
 
a
 
IIb
 
b
 
3 responds to intracel-
lular signals by binding fibrinogen and triggering cy-
toskeletal reorganization, but the mechanisms of 
 
a
 
IIb
 
b
 
3 signaling remain poorly understood. To better 
understand this process, we established conditions to 
study 
 
a
 
IIb
 
b
 
3 signaling in primary murine megakaryo-
cytes. Unlike platelets, these platelet precursors are 
amenable to genetic manipulation. Cytokine-stimu-
lated bone marrow cultures produced three arbitrary 
populations of 
 
a
 
IIb
 
b
 
3-expressing cells with increasing 
size and DNA ploidy: small progenitors, intermediate-
size young megakaryocytes, and large mature mega-
karyocytes. A majority of the large megakaryocytes 
bound fibrinogen in response to agonists, while almost 
none of the smaller cells did. Fibrinogen binding to 
large megakaryocytes was inhibited by Sindbis virus-
mediated expression of isolated 
 
b
 
3 integrin cytoplasmic 
tails. Strikingly, large megakaryocytes from mice defi-
cient in the transcription factor NF-E2 failed to bind
fibrinogen in response to agonists, despite normal
surface expression of 
 
a
 
IIb
 
b
 
3. Furthermore, while 
megakaryocytes from wild-type mice spread on immo-
bilized fibrinogen and exhibited filopodia, lamellipodia 
and Rho-dependent focal adhesions and stress fibers, 
NF-E2–deficient megakaryocytes adhered poorly. 
These studies establish that agonist-induced activation 
of 
 
a
 
IIb
 
b
 
3 is controlled by NF-E2–regulated signaling 
pathways that mature late in megakaryocyte develop-
ment and converge at the 
 
b
 
3 cytoplasmic tail. Mega-
karyocytes provide a physiologically relevant and
tractable system for analysis of bidirectional 
 
a
 
IIb
 
b
 
3
signaling.
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I
 
NTEGRIN
 
 
 
a
 
IIb
 
b
 
3 functions in platelets as an adhesion
receptor for fibrinogen and von Willebrand factor and
as a signaling receptor that regulates organization of
the cytoskeleton (Fox, 1996; Hartwig et al., 1996; Shattil et
al., 1998). The adhesive and signaling functions of 
 
a
 
IIb
 
b
 
3
are closely intertwined. For example, ligand binding to
 
a
 
IIb
 
b
 
3 is regulated by inside out signals that control
receptor affinity and avidity (Ginsberg et al., 1992), while
outside in signals triggered by integrin ligation influence
platelet shape, granule secretion, and clot retraction
(Schoenwaelder et al., 1994; Hartwig et al., 1996; Yuan et al.,
1997; Jenkins et al., 1998; Leng et al., 1998). Until recently,
 
most studies of 
 
a
 
IIb
 
b
 
3 were conducted using platelets
or, alternatively, immortalized cell lines transfected with
 
a
 
IIb
 
b
 
3 (O’Toole et al., 1994; Qi et al., 1998). These studies
have been useful in formulating a conceptual framework
for integrin signaling that includes a complicated network
of heterotrimeric G proteins, protein and lipid kinases and
phosphatases, phospholipases, proteases, and small GTP-
ases (Fox, 1996; Rittenhouse, 1996; Shattil et al., 1998).
However, a detailed understanding of 
 
a
 
IIb
 
b
 
3 signaling has
been impeded by the inability to manipulate gene expres-
sion in anucleate platelets and by concerns that observa-
tions in cell lines may not be entirely relevant to platelets.
In this context, it is now possible to study platelets in gene-
targeted mice, an advance that is beginning to yield impor-
tant new insights into the structure and function of 
 
a
 
IIb
 
b
 
3
(Holmbäck et al., 1996; Offermanns et al., 1997; Aszódi
et al., 1999; Hauser et al., 1999; Hodivala-Dilke et al., 1999;
Law et al., 1999). Nonetheless, further analysis of 
 
a
 
IIb
 
b
 
3
signaling would be facilitated if there were a means to ma-
nipulate genes ex vivo in an appropriate primary cell.
Megakaryocytes, the direct precursors of platelets, rep-
resent a potential model system to achieve this goal. The
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development of megakaryocytes from hematopoietic stem
cells requires a suitable microenvironment, the action of
specific hematopoietic growth factors, including throm-
bopoietin (TPO)
 
1
 
, and a hierarchy of transcription factors,
including FOG, GATA-1, and NF-E2 (Kaushansky, 1995;
Long, 1998; Vyas et al., 1999). Recombinant growth fac-
tors allow for preferential expansion and maturation of
murine and human megakaryocyte progenitors ex vivo,
enabling biochemical studies to be carried out (Mountford
et al., 1999; Rojnuckarin et al., 1999). In fact, human mega-
karyocytes cultured under such conditions have been
shown to bind fibrinogen or a ligand-mimetic anti-
 
a
 
IIb
 
b
 
3
monoclonal antibody after acute stimulation with TPO,
demonstrating the presence of inside out signaling path-
ways in these cells (Zauli et al., 1997a).
Therefore, we set out to determine whether primary
murine megakaryocytes could be used to further charac-
terize 
 
a
 
IIb
 
b
 
3 signaling and, in effect, bridge the gap be-
tween in vitro experiments with platelets and clinicopatho-
logical analyses of gene-targeted mice. The results validate
this approach and establish that agonist-induced inside out
signaling and fibrinogen binding to 
 
a
 
IIb
 
b
 
3 require a gene
or genes regulated by the transcription factor, NF-E2. Fur-
thermore, these studies show that protein expression can
be manipulated in mature megakaryocytes using Sindbis
virus vectors, enabling a molecular analysis of 
 
a
 
IIb
 
b
 
3 sig-
naling in the appropriate cellular context.
 
Materials and Methods
 
Murine Bone Marrow Cultures
 
All chemicals and reagents were from Sigma Chemical Co. unless indi-
cated otherwise. Initial studies were carried out with wild-type megakaryo-
cytes derived from BALB/C mice. p45 NF-E2–deficient mice (a generous
gift from Drs. Ramesh Shivdasani and Stuart Orkin, Harvard Medical
School, Boston, MA) are in a mixed C57Bl/6-129/Sv background (Shiv-
dasani et al., 1995). When their megakaryocytes were studied, wild-type
mice with a similarly mixed background were used as controls. There was
no obvious difference between wild-type megakaryocytes from these dif-
ferent strains with respect to the 
 
a
 
IIb
 
b
 
3 functions studied. Bone marrow
cells were harvested from 8–9-wk-old mice by flushing both sets of femurs
and tibias with PBS containing 2% bovine serum albumin, 0.38% triso-
dium citrate, and 1 U/ml DNAse. Mononuclear cells were isolated over
Ficoll Hypaque (1.080 g/ml; Pharmacia) after a 30-min centrifugation at
400 
 
g
 
. Low-density mononuclear cells were cultured for up to 9 d at a
starting density of 10
 
6
 
 cells/ml in Iscove’s Modified Dulbecco’s medium
(Irvine Scientific) supplemented as described (Zauli et al., 1997a), and in-
cluding 10 ng/ml murine TPO (a gift from Kirin Brewery Ltd., Japan), mu-
rine IL-6 and human IL-11 (Biosource International, Inc.). Cytospins of
20,000–100,000 cells were stained with Wright-Giemsa to analyze cell
morphology.
 
Flow Cytometry
 
Cell size, antigen expression and DNA ploidy were assessed by flow cy-
tometry. After 0–9 d in culture, bone marrow-derived cells were centri-
fuged at 200 
 
g
 
 for 10 min, washed and resuspended in PBS at 4 
 
3
 
 10
 
6
 
/ml.
Then 50-
 
m
 
l aliquots were incubated for 30 min at 4
 
8
 
C with one of the fol-
lowing antibodies: 10 
 
m
 
g/ml FITC-conjugated anti-
 
a
 
IIb (rat anti–mouse
CD41; PharMingen); biotin anti-mouse GP V (murine clone C24.25.1; a
gift from V. Ramakrishnan, Cor Therapeutics, Inc., South San Francisco,
CA); FITC-anti-Gr-1, a granulocyte marker (rat anti–mouse; PharMin-
gen); phycoerythrin-anti-Sca-1, a progenitor cell marker (rat anti–mouse;
PharMingen); or a 1:1,000 dilution of rabbit anti–mouse GP Ib
 
a
 
 (from V.
 
Ramakrishnan). Negative controls included an irrelevant isotype-matched
rat or mouse antibody (PharMingen) or normal rabbit serum, as needed.
When the primary antibodies were biotin-anti–GP V or rabbit anti-GP
Ib
 
a
 
, the cells were washed and subsequently incubated for 15 min at 4
 
8
 
C
with 20 
 
m
 
g/ml FITC-streptavidin or 14 
 
m
 
g/ml FITC anti-rabbit immuno-
globulin (heavy plus light chains), respectively (Biosource International).
Cells were finally resuspended in PBS containing 1 
 
m
 
g/ml propidium io-
dide and analyzed on a FACSCalibur flow cytometer (Becton Dickinson).
DNA ploidy was assessed as described (Williams et al., 1998).
 
Inside Out Signaling in Megakaryocytes
 
Purified human fibrinogen (Enzyme Research Laboratories) was labeled
with FITC (Shattil et al., 1987). Human fibrinogen was used as a ligand in-
stead of murine fibrinogen because of its wider availability and its capacity
to bind to and support the aggregation of activated murine platelets (Law
et al., 1999). Furthermore, in preliminary studies, murine and human fi-
brinogen were found to be equivalent inhibitors of FITC-human fibrino-
gen binding to agonist-stimulated murine and human platelets. After 6 d
in culture, bone marrow cells were sedimented by gravity for 60 min at
37
 
8
 
C in a 50-ml conical polypropylene tube. In addition to achieving mod-
est enrichment of megakaryocytes, gravity sedimentation limited any
functional damage that might occur to these fragile cells during centrifu-
gation. When the effects of certain inhibitors were studied (see Results),
they or appropriate vehicle control buffer were added at this stage for the
final 20 min. Cells were then gently resuspended to 4 
 
3
 
 10
 
6
 
/ml in modified
Tyrode’s buffer containing 1 mM CaCl
 
2
 
 and 1 mM MgCl
 
2
 
 (O’Toole et al.,
1994) and then incubated for 30 min at room temperature in the presence
of FITC-fibrinogen (250 
 
m
 
g/ml), specific agonists and inhibitors, 10 
 
m
 
g/ml
of the non–function-blocking anti-
 
a
 
IIb antibody, and 20 
 
m
 
g/ml phyco-
erythrin-streptavidin (Molecular Probes). After a 10-fold dilution with
buffer containing 1 
 
m
 
g/ml propidium iodide, fibrinogen binding was quan-
tified by flow cytometry (Pampori et al., 1999).
FITC-fibrinogen binding was monitored in the FL1 channel of the flow
cytometer on the gated subset of viable cells (e.g., negative for propidium
iodide, FL3) that expressed 
 
a
 
IIb
 
b
 
3 (FL2). Preliminary studies indicated
that fibrinogen binding was inhibited 
 
$
 
90% by either 10 mM EDTA
(Law et al., 1999), 5 
 
m
 
M kistrin (an RGD-containing disintegrin known to
block 
 
a
 
IIb
 
b
 
3 function; Adler et al., 1991), or 20 
 
m
 
g/ml 1B5, a function-
blocking hamster monoclonal antibody specific for murine 
 
a
 
IIb
 
b
 
3 (a gift
from B. Coller and S. Smyth, Mt. Sinai Medical Center, New York, NY;
Lengweiler et al., 1999). Therefore, specific fibrinogen binding was de-
fined as binding that was inhibited by kistrin or EDTA. When it was nec-
essary to compare the binding data between subpopulations of cells that
were heterogeneous in size and 
 
a
 
IIb
 
b
 
3 density, specific FITC-fibrinogen
binding was expressed as a percent of maximal binding obtained in the
presence of 1 mM MnCl
 
2
 
, an activator of integrins (Bazzoni and Hemler,
1998).
To determine the effect of isolated integrin cytoplasmic tails on fibrino-
gen binding to megakaryocytes, cDNA encoding chimeric proteins con-
sisting of the extracellular and transmembrane domains of the Tac subunit
of the human IL-2 receptor (CD25) and the human 
 
b
 
3 cytoplasmic tail
(Tac-
 
b
 
3) or the 
 
a
 
5 cytoplasmic tail (Tac-
 
a
 
5; Chen et al., 1994; LaFlamme
et al., 1994) were cloned into a Sindbis virus vector (pSinRep5; Invitro-
gen). As a further control, a tailess Tac construct was also prepared.
 
 
 
Lin-
ear, capped viral RNA was prepared and pseudovirions were produced in
BHK cells using a Sindbis Expression System (Invitrogen). Pseudovirion
titers were such that a 1:3,000 dilution of BHK cell supernatant infected
virtually all BHK cells in a 100-mm dish, as determined by surface expres-
sion of Tac using a phycoerythrin-conjugated antibody to human CD25
(PharMingen). To infect megakaryocytes, day 5 bone marrow cells were
suspended in a 1:1.5 dilution of virus for 1 hand then diluted with 7 vol of
serum-free medium and cultured for another 24 h. The cells were stained
with FITC-fibrinogen, phycoerythrin-anti–human CD25 (PharMingen),
and propidium iodide, and fibrinogen binding to large, viable megakaryo-
cytes was quantified by flow cytometry.
 
Outside In Signaling in Megakaryocytes
 
Bone marrow-derived cells were cultured for 5 or 6 d, allowed to settle by
gravity for 1 h and resuspended to 2 
 
3
 
 10
 
5
 
/ml in buffer containing 137 mM
NaCl, 2.7 mM KCl, 3.3 mM NaH
 
2
 
PO
 
4
 
, 1 mM MgCl
 
2
 
, and 3.8 mM Hepes,
pH 7.35. Cells were then incubated on fibrinogen-coated coverslips for 45
min at 37
 
8
 
C in the presence or absence of 100 nM phorbol myristate ace-
tate, the latter added to activate protein kinase C and enhance cell spread-
 
1. 
 
Abbreviations used in this paper:
 
 CAT, chloramphenicol acyltrans-
ferase; TPO, thrombopoietin.
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ing (Leng et al., 1998). After removing nonadherent cells, the adherent
cells were fixed in 3.7% formaldehyde, permeabilized with 0.2% Triton
X-100 in PBS, and stained with monoclonal anti-vinculin antibody, FITC-
anti-mouse IgG and rhodamine-phalloidin. Cells were then analyzed by
confocal laser scanning microscopy and photomicrographs were prepared
using Adobe Photoshop 5.0 (Hato et al., 1998; Leng et al., 1998).
In some experiments, megakaryocytes from day 5 cultures were in-
fected with recombinant Sindbis virus expressing either C3 exoenzyme, an
inhibitor of Rho GTPase (Aktories et al., 1992; Sindbis/C3), or chloram-
phenicol acyl transferase (Sindbis/CAT; kind gifts from Drs. C.S. Hahn,
University of Virginia and M.A. Schwartz, Scripps Research Institute).
Viral stocks were produced and titered in BHK cells as described (Bobak
et al., 1997; Hahn et al., 1992). For infection, megakaryocytes were al-
lowed to adhere to fibrinogen-coated coverslips for 30 min at 37
 
8
 
C and in-
cubated with Sindbis/C3 or Sindbis/CAT for 1 h at 37
 
8
 
C at a multiplicity of
infection of 50. After washing, the cells were incubated another 2.5 h in
buffer, and 100 nM phorbol myristate acetate was added for the final 30
min to enhance spreading. After washing, adherent cells were fixed, per-
meabilized, stained, and examined by confocal microscopy. In parallel,
some cells were infected on fibrinogen-coated plastic dishes, scraped into
SDS sample buffer, and 50-
 
m
 
g aliquots were subjected to SDS-PAGE un-
der reducing conditions (Laemmli, 1970). After transfer to nitrocellulose,
blots were probed with a rabbit polyclonal antibody specific for Sindbis
E1 protein (a gift from J.H. Strauss, California Institute of Technology,
Pasadena, CA) or with a murine monoclonal antibody to Rho (Santa Cruz
Biotechnology, Santa Cruz, CA). Blots were developed for 0.5–2 min by
chemiluminescence (ECL; Amersham Corp.).
 
Results
 
a
 
IIb
 
b
 
3 and Megakaryocyte Development
 
To obtain primary murine megakaryocytes for studies of
 
a
 
IIb
 
b
 
3 signaling, a low-density fraction of bone marrow
was cultured in serum-free medium containing 10 ng/ml
TPO, IL-6, and IL-11. Total cell number decreased pro-
gressively by 45, 73, and 89% on days 3, 6, and 9, respec-
tively. On the other hand, Wright-Giemsa staining showed
a progressive increase in the proportion of large, polyploid
cells, such that by day 6 both small, immature megakaryo-
cytes with basophilic cytoplasm and larger, mature mega-
karyocytes with granular, eosinophilic cytoplasm were
readily apparent (Fig. 1). The vast majority of cells on
day zero were small, as assessed by flow cytometric light
scatter (Fig. 2 A). However, by day 3 a subpopulation of
larger cells of intermediate size was evident, and by day 6 a
subpopulation of large cells was present, typically amount-
ing to 5–10% of the total. When the large cells were
FACS-sorted and stained, they consisted of mature mega-
karyocytes (Fig. 1 G). The relative proportion of large
megakaryocytes decreased slightly by day 9 in culture, pre-
sumably the result of programmed cell death (Fig. 2 A;
Zauli et al., 1997b). On day 6, the DNA ploidy of the small
cells was 2N, while that of the intermediate-size and large
cells ranged from 2-32N and 8-128N, respectively (Fig. 2 B).
Surface antigen expression was characterized by flow
cytometry (Table I). The proportion of 
 
a
 
IIb
 
b
 
3-expressing
cells increased progressively with time and by day 6 it rep-
resented 21% of all small cells, 98% of the intermediate-
size cells and 
 
.
 
99% of the large cells. On day zero, 15% of
the small cells were positive for 
 
a
 
IIb
 
b
 
3, due in part to the
Figure 1. Morphology of
murine bone marrow cells.
Bone marrow was harvested
and maintained in culture as
described in Materials and
Methods. Wright-Giemsa-
stained cytospin prepara-
tions after zero (A), 3 (B), 6
(C), and 9 (D) d demon-
strated an increase in the pro-
portion of megakaryocytes
over time. Day 6 cells were
sorted on the basis of size, as
determined by flow cytomet-
ric light scatter profiles (see
Fig. 2 A). E, illustrates the
sorted small cells; F, interme-
diate-size cells; and G, large
cells. The objective lens
was 203.
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presence of platelets. Throughout the culture period, a
significant minority of the cells expressed Sca-1 (Table
I), and some coexpressed aIIbb3, suggesting that they
were committed megakaryocyte progenitors. Expression
of components of the platelet GP Ib-V-IX complex ap-
peared to lag behind expression of aIIbb3 because not ev-
ery aIIbb3-expressing cell was positive for GP Ib or GP V
(Table I). Moreover, some cells expressed GP Ib but not
GP V, suggesting that GP V is not required for GP Ib ex-
pression. On day 6, most of the small cells were positive
for the myeloid marker, Gr-1, as were 53% of the interme-
diate-size cells and 2% of the large cells. Taken together,
these results indicate that murine megakaryocytes can un-
dergo progressive expansion and maturation in culture,
permitting a detailed analysis of aIIbb3 signaling during
megakaryocyte development.
aIIbb3 Signaling in Developing Megakaryocytes
Inside out signaling in aIIbb3-expressing megakaryocyte
progenitors and developing megakaryocytes was assessed
on day 6 of culture by measuring the agonist-dependent
binding of a saturating concentration of FITC-fibrinogen.
Large megakaryocytes bound little or no fibrinogen in the
absence of an agonist (Fig. 3 A). On the other hand, spe-
cific fibrinogen binding was observed after a 30-min incu-
bation of the cells with 10 ng/ml SDF-1a, a CXCR4 recep-
tor agonist (Riviere et al., 1999; Wang et al., 1998) or 100
ng/ml TPO, the agonist for c-Mpl receptors (Kaushansky,
1999). Fibrinogen binding was even greater in response to
typical platelet agonists, including 10–100 mM ADP plus
epinephrine, 0.5 U/ml thrombin, or 2 mM PAR4 thrombin
receptor-activating peptide (GYPGKF; Kahn et al., 1998;
Fig. 3 A). Although higher concentrations of these ago-
nists did not stimulate additional fibrinogen binding, com-
binations of three or more agonists markedly increased
fibrinogen binding, in some cases equivalent to that ob-
tained with MnCl2 (Fig. 3 A). None of the agonists in-
creased surface expression of aIIbb3.
Fibrinogen binding induced by the combination of
PAR4-activating peptide, ADP, and epinephrine was in-
hibited .80% by preincubation of the cells with 2 mM
PGI2 or PGE1, compounds that inhibit platelet aggrega-
tion through receptor-mediated stimulation of adenylyl
Figure 2. Size and DNA ploidy
of murine bone marrow cells.
Cells cultured as in Fig. 1 were
characterized by flow cytometry
as described in Materials and
Methods. A shows dot plots for
forward (FSC) and side (SSC)
light scatter profiles of 10,000
cells. In each plot, three arbitrary
analysis gates have been drawn.
The gate at the lower left in-
cludes small cells, the middle
gate intermediate-size cells, and
the gate at the upper right large
cells. Note a progressive increase
in the proportion of intermedi-
ate-size and large cells with time.
In B, cells on day 6 of culture
were analyzed for DNA content.
Note the increase in ploidy with
cell size.
Table I. Expression of Surface Markers during Ex Vivo Expansion of Megakaryocytes
Day 0 Day 3 Day 6 Day 9
Small Small Medium Large Small Medium Large Small Medium Large
aIIb 15.3* 5.9 50.6 99.5 21.4 98.1 99.7 27.9 72.0 99.4
GP Iba 1.9 5.1 50.5 90.8 11.4 78.8 84.6 17.0 56.7 92.1
GP V 8.9 7.8 29.2 54.6 14.9 45.4 53.3 21.7 54.4 88.9
Sca-1 12.6 18.1 45.1 32.1 7.6 27.2 11.0 13.3 21.1 22.1
Gr-1 57.6 88.6 49.1 8.9 86.8 53.3 2.5 90.7 53.8 14.7
*Values represent the percentage of cells expressing a given surface marker and are the average of two independent experiments, each performed in duplicate.
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cyclase (Hawiger et al., 1980). In addition, fibrinogen
binding was inhibited 48% by 100 nM wortmannin, an in-
hibitor of certain PI 3-kinases, 40% by 12 mM bisindolyl-
maleimide, a protein kinase C inhibitor, and 57% by 100 mM
BAPTA-AM, a chelator of cytoplasmic free Ca21. In con-
trast, preincubation of cells with 1 mM aspirin to inhibit
cyclooxygenase had no effect on fibrinogen binding, al-
though it did inhibit the response to arachidonic acid as
expected. Collectively, these results indicate that excita-
tory agonists can stimulate and certain inhibitory agonists
can block the ligand binding function of aIIbb3 in large
megakaryocytes, just as in platelets. Furthermore, activa-
tion of aIIbb3 is regulated in a positive fashion by signal-
ing pathways that likely involve PI 3-kinase, protein kinase
C, and free Ca21, and in a negative fashion by cyclic AMP.
Fig. 3 B shows that up to 60% of large megakaryocytes
bound fibrinogen in response to agonists. To place this in
perspective, $90% of agonist-activated blood platelets ob-
tained from the same donor mice bound fibrinogen (not
shown). The lack of responsiveness of some large mega-
karyocytes appeared to be due to impaired signaling to
aIIbb3 because FITC-fibrinogen binding to all of the large
cells could be induced with MnCl2. Furthermore, very few
intermediate-size megakaryocytes and no small aIIbb3-
expressing cells bound fibrinogen in response to the ago-
nists depicted in Fig. 3 or in response to as much as 500 nM
phorbol myristate acetate to activate protein kinase C.
The results were similar if fetal hematopoietic tissue from
the livers of day 14.5 murine fetuses was used instead of
bone marrow as the source of megakaryocyte progenitors
(not shown; Lecine et al., 1998a). Overall, these results in-
dicate that inside out signaling pathways responsible for
activation of aIIbb3 become fully developed only late in
megakaryocyte development.
Platelet adhesion to an immobilized aIIbb3 ligand trig-
gers the reorganization of actin filaments, filopodial and
lamellipodial extension, and cell spreading (Nachmias and
Golla, 1991; Yuan et al., 1997; Hagmann et al., 1998; Leng
et al., 1998). To determine if megakaryocytes can engage
in such outside in signaling, day 6 bone marrow cultures
were incubated on fibrinogen-coated coverslips for 45 min.
By this time, most of the large megakaryocytes had be-
come adherent, and this response was aIIbb3-dependent
because it could be blocked by 5 mM kistrin. Adherent
megakaryocytes ranged in diameter from 10 to .50 mm,
and many exhibited filopodia and lamellipodia (Fig. 4, A
and C). When 100 nM phorbol myristate acetate was
present, the megakaryocytes spread more extensively and
most now exhibited focal adhesions and stress fibers (Fig.
4, B and D). Actin filaments were often circumferential
and parallel to the cell margins, rather than perpendicular
as in fibroblasts, an observation made previously with
guinea pig megakaryocytes (Leven and Nachmias, 1982).
These results indicate that ligand binding to aIIbb3 can
promote cytoskeletal reorganization in megakaryocytes,
accompanied by changes in cell shape.
Mechanisms of aIIbb3 Signaling in Megakaryocytes
Studies of mice deficient in the p45 subunit of NF-E2 have
revealed that this transcription factor is necessary for the
final phases of megakaryocyte development and platelet
Figure 3. Fibrinogen binding to aIIbb3-expressing megakaryo-
cyte progenitors and megakaryocytes. Bone marrow cells on day
6 of culture were stimulated with the indicated agonists in the
presence of FITC-fibrinogen, a non–function-blocking anti-aIIb
antibody (to identify aIIbb3-expressing cells), and propidium io-
dide (to exclude dead cells). Agonist concentrations were: SDF-1a,
10 ng/ml; TPO, 100 ng/ml; ADP and Epi(nephrine), 100 mM
each; Thrombin, 0.5 U/ml; and PAR4 receptor-activating pep-
tide, 2 mM. The data in A depict specific fibrinogen binding de-
termined by flow cytometry and are expressed as a percent of
maximum specific binding obtained in response to MnCl2. Fibrin-
ogen binding in B is expressed as the percent of cells that stained
positive for FITC-fibrinogen. Data represent the means 6 SEM
of five separate experiments.
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production (Shivdasani et al., 1995; Lecine et al., 1998b).
Since inside out signaling to aIIbb3 was fully developed
only in mature megakaryocytes (Fig. 3), we considered
whether genes regulated by NF-E2 might be required for
aIIbb3 activation. Accordingly, bone marrow from NF-
E22/2 mice was cultured for 6 days with TPO, IL-6, and
IL-11, yielding a subpopulation of large megakaryocytes
similar to wild-type and NF-E21/2 controls. However, un-
like cells from wild-type or NF-E21/2 mice, large NF-E22/2
megakaryocytes displayed a virtual absence of FITC-
fibrinogen binding in response to the combination of
PAR4 thrombin receptor-activating peptide, epinephrine,
and ADP (Fig. 5). Similar results were obtained when the
cells were stimulated with as much as 500 nM phorbol
myristate acetate. This impairment of fibrinogen binding
was due to a defect in inside out signaling because NF-E22/2
megakaryocytes expressed normal amounts of aIIbb3 on
their surfaces, and they bound FITC-fibrinogen as well
as wild-type or NF-E21/2 megakaryocytes in response to
MnCl2 (Fig. 5). These results indicate that NF-E2, or more
likely genes regulated by NF-E2, are required for agonist-
induced activation of aIIbb3.
In fibroblastic cell lines, the heterologous expression of
membrane-tethered b3 integrin cytoplasmic tails (in the
form of a human Tac-b3 fusion protein) can reverse the
high-affinity state of a constitutively active mutant of
aIIbb3. In contrast, Tac-a5 tails have no such effect (Chen
et al., 1994). To determine if chimeric b3 tails could block
agonist-induced activation of aIIbb3, day 5 bone marrow
cultures were incubated for 1 h with Sindbis pseudovirions
expressing Tac-b3 RNA or, as a control, pseudovirions ex-
pressing Tac-a5. 24 h later, flow cytometry showed that
the Tac chimeras had been expressed in 5–20% of large
megakaryocytes. Under these conditions, Sindbis virus in-
fection did not affect either aIIbb3 surface expression or
megakaryocyte viability. Large megakaryocytes express-
ing relatively low levels of Tac-b3 or Tac-a5 bound fibrin-
ogen in response to agonists almost as well as noninfected
cells. In contrast, megakaryocytes expressing relatively
high levels of Tac-b3 bound very little fibrinogen, and sig-
nificantly less than cells expressing high levels of Tac-a5
(P , 0.01; Fig. 6). The more modest reduction in fibrino-
gen binding in cells expressing high levels of Tac-a5 was
also observed with a tailless Tac construct (not shown),
suggesting that it might have been due to viral infection,
per se. Since Tac-b3 cannot form a heterodimer with aIIb
but may nevertheless interact with cytoplasmic proteins
that normally bind to aIIbb3 (Chen et al., 1994), these re-
sults suggest that one or more b3 cytoplasmic tail-binding
proteins mediates physiological activation of aIIbb3.
To explore mechanisms of outside in signaling in mega-
karyocytes, cells adherent to fibrinogen were exposed for
1 h to Sindbis virus encoding C3 exoenzyme, which ADP-
ribosylates and inactivates the small GTPase, Rho (Akto-
Figure 4. Distribution of vin-
culin and F-actin in large
megakaryocytes adherent to
fibrinogen. Megakaryocytes
from day 6 cultures were in-
cubated for 45 min on fibrin-
ogen-coated coverslips in the
absence (A and C) or pres-
ence (B and D) of 100 nM
phorbol myristate acetate.
The cells were fixed, per-
meabilized and stained to vi-
sualize vinculin (green) and
F-actin (red) by confocal mi-
croscopy. Each panel shows a
0.2-mm confocal image taken
near the ventral surface of a
representative cell. The ar-
rowheads in D point to vin-
culin-rich focal adhesions,
and the arrow points to actin
stress fibers. This experi-
ment is representative of
three so performed. Bar,
10 mm.
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ries et al., 1992; Moorman et al., 1999). After subsequent
incubation in the presence of phorbol myristate acetate to
enhance cell spreading, cytoskeletal organization was ana-
lyzed. Both Sindbis/C3 and a control virus, Sindbis/CAT,
infected adherent cells, as evidenced by the time-depen-
dent expression of the 61-kD viral E1 protein on Western
blots of cell lysates (not shown). Infection with Sindbis/C3
was associated with a reduction in the percent of mega-
karyocytes that contained focal adhesions and stress fibers
(Fig. 7, A and B). Whereas 70% of adherent megakaryo-
cytes incubated with Sindbis/CAT displayed focal adhe-
sions and stress fibers, only 30% of cells incubated with
Sindbis/C3 did so (Fig. 7 C, P , 0.001). Furthermore, the
remaining stress fibers in Sindbis/C3-treated megakaryo-
cytes were often thinner and less densely packed than in
the control cells. The effect of Sindbis/C3 on the mega-
karyocyte cytoskeleton could reasonably be attributed to
ADP-ribosylation of Rho, because z50% of this protein
in cell lysates displayed a retarded electrophoretic mobil-
ity characteristic of ribosylation (Fig. 7 C, inset). In con-
trast to its effect on focal adhesions and stress fibers, Sind-
bis/C3 did not appear to impair megakaryocyte spreading
or the formation of filopodia and lamellipodia. Thus, Rho
is responsible for a subset of cytoskeletal responses in
megakaryocytes that is triggered, in part, by outside in sig-
naling through aIIbb3.
Discussion
A common strategy to characterize intracellular signaling
pathways is to express wild-type and mutant gene products
and observe the effects on cell function. Unfortunately,
this approach cannot be used to characterize integrin
signaling in platelets because of inherent difficulties in
expressing recombinant proteins in these anucleate cells.
Consequently, we hypothesized that primary murine mega-
karyocytes might serve as a relevant and tractable model
system for studies of aIIbb3 signaling. Culture of murine
bone marrow in the presence of TPO, IL-6, and IL-11 led
to megakaryocyte expansion and maturation, allowing
functional studies of aIIbb3 and the following conclusions
to be drawn. (a) As with platelets, megakaryocytes are ca-
pable of inside out signaling to control agonist-induced fi-
brinogen binding to aIIbb3. This process becomes fully
functional late in megakaryocyte development, requires a
gene or genes regulated by transcription factor NF-E2,
and converges on the b3 cytoplasmic tail. (b) As with
platelets, the adhesion of megakaryocytes to immobilized
fibrinogen triggers outside in signals through aIIbb3 that
lead to cell spreading and cytoskeletal reorganization. Ad-
herent megakaryocytes exhibit filopodia, lamellipodia,
and Rho-dependent focal adhesions and stress fibers. (c)
Sindbis virus vectors can be used to express heterologous
proteins in megakaryocytes, enabling aIIbb3 signaling to
be studied in a physiological context in ways not possible
with platelets.
Figure 5. Effect of NF-E2 deficiency on agonist-induced fibrino-
gen binding to large megakaryocytes. In A, fibrinogen binding to
large megakaryocytes was assessed as in Fig. 3 and expressed as
mean fluorescence intensity. The concentration of PAR4 recep-
tor-activating peptide was 2 mM, ADP and Epi(nephrine) were
100 mM each and MnCl2 was 1 mM. NF-E22/2 and wild-type
megakaryocytes were directly compared in 4 separate experi-
ments (means 6 SEM), and NF-E21/2 megakaryocytes were also
studied on one of these occasions. Note that unlike their wild-
type and NF-E21/2 counterparts, the NF-E22/2 megakaryocytes
failed to bind fibrinogen in response to agonists, but did so in re-
sponse to MnCl2. In B, aIIbb3 expression in wild-type and NF-
E22/2 megakaryocytes was compared on one occasion using an
anti-aIIb antibody.
Figure 6. Effects of chimeric integrin cytoplasmic tails on ago-
nist-induced fibrinogen binding to large megakaryocytes. After 5 d
in culture, megakaryocytes in suspension were infected with
Sindbis virus expressing either the Tac-b3 cytoplasmic tail or the
Tac-a5 tail, as described in Materials and Methods. 24 h later,
Tac expression and FITC-fibrinogen binding to large megakaryo-
cytes were studied by flow cytometry. Arbitrary analysis gates
were placed around megakaryocytes that expressed no Tac, rela-
tively low levels of Tac, and relatively high levels of Tac. Data
represent the means 6 SEM of seven separate experiments.
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Mechanisms of Inside Out Signaling in Megakaryocytes
In both human and murine platelets, ligand binding to
aIIbb3 is regulated by signaling events that modulate inte-
grin affinity and/or avidity (Shattil et al., 1998; Tsakiris et al.,
1999). In platelets, the use of selective enzyme inhibi-
tors has implicated protein and lipid kinases, such as PI
3-kinase and protein kinase C, in receptor-mediated activa-
tion of aIIbb3. However, the mechanism by which effectors
modulate aIIbb3 function is unknown. A recent report
concluded that human bone marrow-derived megakaryo-
cytes stimulated with TPO adhere to immobilized fibrino-
gen in a manner dependent on aIIbb3 and PI 3-kinase
(Zauli et al., 1997a). The present studies establish that the
binding of soluble fibrinogen to aIIbb3 is regulated in mu-
rine megakaryocytes. Unstimulated megakaryocytes failed
to bind soluble fibrinogen, indicating that aIIbb3 is in a
default low affinity/avidity state. Stimulation with ago-
nists, including TPO and substances that interact with G
protein-linked receptors (SDF-1a, thrombin, PAR4 recep-
tor-activating peptide, ADP, epinephrine), caused rapid
activation of aIIbb3 and fibrinogen binding to a majority
of mature megakaryocytes (Fig. 3). In fact, a combination
of agonists caused as much fibrinogen binding as did
MnCl2, an activator of integrins (Bazzoni and Hemler,
1998). Platelet aggregation inhibitors, such as PGI2 and
PGE1 as well as inhibitors of PI 3-kinase and protein ki-
nase C, blocked agonist-induced fibrinogen binding. Thus,
aIIbb3 is likely subject to similar regulatory mechanisms
in mature megakaryocytes and in platelets.
A consistent finding in this study was that few interme-
diate-size megakaryocytes and no small aIIbb3-expressing
progenitors bound fibrinogen in response to agonists (Fig.
3 B). This failure could not be explained by a lack of
aIIbb3 expression, by prior binding of ligands to aIIbb3
during culture, or by structural alterations in the integrin,
since these cells could bind fibrinogen in response to
MnCl2. The most likely explanation for these observations
is that inside out signaling pathways to aIIbb3 become
fully developed relatively late in megakaryocytopoiesis.
Developmental regulation of aIIbb3 affinity/avidity, as
opposed to regulation of aIIbb3 expression, could have
beneficial in vivo consequences by limiting the binding of
soluble adhesive ligands to aIIbb3 on progenitors and
young megakaryocytes, thereby preventing their unneces-
sary aggregation. At the same time, the presence of
aIIbb3 on the surface of these cells, even in a low affinity/
avidity state, might enable them to adhere to fibrinogen or
other ligands in the extracellular matrix (Savage et al.,
1992), and to initiate outside in signals (Haimovich et al.,
1993).
The most striking finding in this study was an inability of
p45 NF-E22/2 megakaryocytes to bind fibrinogen in re-
sponse to agonists (Fig. 5). NF-E2 contains a 45-kD sub-
unit that is restricted to hematopoietic cells and a ubiqui-
tous 18-kD subunit (Andrews, 1998). Since p45 and p18
hetero-oligomers are required for transcriptional activa-
tion, the results with p45-deficient megakaryocytes suggest
that one or more genes regulated by NF-E2 are required
for full inside out signaling. This discovery would have
been difficult to validate and explore in platelets because
NF-E22/2 mice have so few circulating platelets (Shiv-
dasani et al., 1995). In addition to highlighting the value of
the megakaryocyte model, these results suggest that the
identification and characterization of NF-E2–regulated
Figure 7. Effect of C3 exoenzyme on outside in signaling through aIIbb3 in megakaryocytes. After 5 d in culture, fibrinogen-adherent
megakaryocytes were infected with Sindbis virus expressing either CAT or C3 exoenzyme as described in Materials and Methods. Cells
were then incubated for another 2.5 h, the last 30 min of which 100 nM phorbol myristate acetate was added to enhance spreading. Af-
ter fixation and staining as in Fig. 4, the cells were analyzed by confocal microscopy. A and B show representative confocal images of
cells infected with Sindbis/CAT and Sindbis/C3, respectively. Note the prominent vinculin-rich focal adhesions (arrowheads) and stress
fibers (arrow) in A, but not in B. In C, 100 adherent megakaryocytes treated with each virus were scored for focal adhesions and stress
fibers by two independent observers. Data are the means 6 SEM of three separate experiments. The inset shows a Western blot of cell
lysates probed with an antibody against Rho. In three such experiments, the intensity of the slower migrating (ADP-ribosylated) Rho
band from Sindbis/C3-infected cells averaged 50% of the total Rho. Bar, 10 mm.
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genes should advance our understanding of the mecha-
nisms of inside out regulation of aIIbb3.
Recently, an in vivo immunoselection strategy was used
to identify thromboxane synthase as a p45 NF-E2 target
gene in the HEL cell megakaryoblastic cell line (Deveaux
et al., 1997). In platelets, this enzyme is responsible for the
conversion of prostaglandin endoperoxides to thrombox-
ane A2. Since thromboxane A2 is a platelet agonist, a defi-
ciency of thromboxane synthase in NF-E22/2 megakaryo-
cytes could, in theory, help to explain the inside out
signaling defect in these cells. However, this is unlikely for
several reasons. First, most investigators including our-
selves have found that agonists such as thrombin, ADP,
and epinephrine stimulate little or no fibrinogen binding
to HEL cells or to other megakaryoblastic cell lines. Thus,
although these cells express thromboxane synthase, they
appear to lack critical intermediates required for inside
out signaling (Jennings et al., 1996; Cichowski et al., 1999).
Second, we found that large megakaryocytes from wild-
type mice bound fibrinogen in response to PAR4 peptide,
ADP, and epinephrine even after treatment with aspirin,
which blocks cyclooxygenase and subsequent production
of thromboxane A2 (Roth et al., 1975). Third, thrombox-
ane A2 is not involved in the initial activation of aIIbb3 in
platelets, but rather reinforces the responses to other ago-
nists (Thomas et al., 1998). It is now feasible, and may be
preferable, to use primary megakaryocytes instead of
megakaryoblastic cell lines to identify NF-E2–regulated
genes involved in aIIbb3 signaling.
Sindbis virus-mediated expression of Tac-b3 integrin cy-
toplasmic tails in megakaryocytes caused dose-dependent
inhibition of agonist-induced fibrinogen binding to aIIbb3
(Fig. 6). Although expressed to the same extent as Tac-b3,
Tac-a5 caused significantly less inhibition of agonist-induced
fibrinogen binding to megakaryocytes (P , 0.01), and the
extent of inhibition was identical to that observed with a
tailless Tac construct. The marked inhibitory effect of Tac-b3
is consistent with the suggestion that overexpressed b3
tails may bind and titrate cytoplasmic proteins that other-
wise would interact with aIIbb3 to regulate receptor affin-
ity or avidity (Chen et al., 1994; LaFlamme et al., 1994).
Several proteins have been shown to interact with the b3
tail in model systems and by affinity chromatography, in-
cluding cytoskeletal proteins such as talin, a-actinin, fil-
amin, and myosin, a 14-kD polypeptide called b3-endo-
nexin, and the cytoplasmic tail of aIIb (Otey et al., 1993;
Haas and Plow, 1996; Hemler, 1998; Jenkins et al., 1998;
Pfaff et al., 1998). In principle, any or all of these interac-
tions with the b3 tail might influence the conformation or
oligomerization state of aIIbb3 and, therefore, its ligand
binding properties (Kucik et al., 1996; Kashiwagi et al.,
1997; Sampath et al., 1998; Bennett et al., 1999).
Mechanisms of Outside In Signaling in Megakaryocytes
The adhesion of platelets to surfaces coated with fibrino-
gen or von Willebrand factor triggers tyrosine phosphory-
lation of numerous proteins, cell spreading, and actin rear-
rangements (Haimovich et al., 1993; Heemskerk et al.,
1997; Yuan et al., 1997; Leng et al., 1998). In the current
study, we found that murine megakaryocytes also adhere
to fibrinogen via aIIbb3 and undergo spreading and cy-
toskeletal reorganization in an aIIbb3-dependent fashion,
particularly in the presence of a costimulus like phorbol
myristate acetate (Fig. 4). This response is similar in some
respects to the morphological changes and actin rear-
rangements in fibroblasts that are triggered by the combi-
nation of cell adhesion via b1 integrins and stimulation by
growth factors (Burridge and Chrzanowska-Wodnicka,
1996). b1 integrins (a4b1 and a5b1) have been demon-
strated to play key roles in hematopoietic cell develop-
ment, presumably by mediating outside in signaling (Ver-
faillie, 1998). In addition, b1 integrins in mature human or
guinea pig megakaryocytes can support attachment and
spreading on fibronectin and focal adhesion formation
(Berthier et al., 1998; Schick et al., 1998). In contrast, other
than regulation of fibrinogen uptake into a-granules, very
little is known about the function of aIIbb3 in megakaryo-
cytes (Handagama et al., 1993).
aIIbb3 signaling cannot be essential for megakaryocyto-
poiesis or thrombopoiesis because platelet numbers are
normal in mice and humans deficient in aIIbb3 (Hodivala-
Dilke et al., 1999). This is not to say, however, that aIIbb3
plays no role in these processes. For example, proplatelet
and platelet formation may involve a series of membrane
protrusive events which could involve integrin-triggered
cytoskeletal reorganization (Choi et al., 1995; Lecine et al.,
1998b). In support of this, certain anti-aIIbb3 antibodies
can inhibit proplatelet formation by cultured megakaryo-
cytes (Takahashi et al., 1999). The formation of filopodia,
lamellipodia, and focal adhesions in fibrinogen-adherent
megakaryocytes (Fig. 4) suggests that signals from aIIbb3
may activate Rho family GTPases, including cdc42, Rac,
and Rho (Hall, 1998). Rho in particular is implicated by
the reduction in focal adhesions and stress fibers in mega-
karyocytes transduced with C3 exoenzyme (Fig. 7). Since
Rho GTPases may become activated during integrin-
mediated cell adhesion (Ren et al., 1999) and signal to the
cytoskeleton and nucleus (Hall, 1998; Treisman et al.,
1998), we suggest that signals downstream of aIIbb3 may
play some adjunctive role in megakaryocyte or platelet de-
velopment. In this context, antibody or peptide blockade
of ligand binding to aIIbb3 has been shown to impair hu-
man megakaryocyte colony formation in a fibrin gel (Zauli
et al., 1997a), and treatment of a human megakaryoblastic
cell line with C3 exoenzyme caused an increase in DNA
ploidy (Takada et al., 1996). Further studies of the role of
aIIbb3 signaling in megakaryocytes are warranted.
Retroviruses and lentiviruses are being evaluated as
transfer vectors for gene therapy, and they also hold prom-
ise for studies of megakaryocyte function (Burstein et al.,
1999; Miyoshi et al., 1999; Murphy and Leavitt, 1999; Wil-
cox et al., 1999). The present experiments show that Sind-
bis virus vectors provide an alternative way to achieve
transient expression of recombinant proteins in terminally
differentiated hematopoietic cells like megakaryocytes.
Transient expression may be particularly useful in situa-
tions where long-term expression of a recombinant pro-
tein might interfere with cell growth or differentiation, as
with C3 exoenzyme and Tac-b3 (Henning et al., 1997;
Lukashev et al., 1994). Taken together with new strategies
to achieve megakaryocyte-specific gene expression in vivo
(Murphy and Leavitt, 1999), several complementary ap-
proaches are now available to manipulate gene expression
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in megakaryocytes, establishing these cells as an ideal sys-
tem for determining the molecular basis of aIIbb3 sig-
naling.
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